000 | 01741 a2200457 4500 | ||
---|---|---|---|
005 | 20250516213213.0 | ||
264 | 0 | _c20150420 | |
008 | 201504s 0 0 eng d | ||
022 | _a1531-8257 | ||
024 | 7 |
_a10.1002/mds.25909 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMahmoudi, Souha | |
245 | 0 | 0 |
_aUpregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. _h[electronic resource] |
260 |
_bMovement disorders : official journal of the Movement Disorder Society _cAug 2014 |
||
300 |
_a1125-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aCebus |
650 | 0 | 4 |
_aClozapine _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine Antagonists _xtoxicity |
650 | 0 | 4 |
_aEnkephalins _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHaloperidol _xtoxicity |
650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
650 | 0 | 4 |
_aMovement Disorders _xetiology |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 | _aOvariectomy |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xgenetics |
650 | 0 | 4 |
_aReceptors, Dopamine D3 _xgenetics |
650 | 0 | 4 |
_aSulpiride _xanalogs & derivatives |
650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacokinetics |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aLévesque, Daniel | |
700 | 1 | _aBlanchet, Pierre J | |
773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 29 _gno. 9 _gp. 1125-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.25909 _zAvailable from publisher's website |
999 |
_c23835200 _d23835200 |